The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
The INFLUENTIAL Trial - Inpatient FLU Vaccination Program Effectiveness: National Trial Implementing Best Practices and Learning Collaboratives
University of Colorado, Denver
22,000 participants
Oct 31, 2024
INTERVENTIONAL
Conditions
Summary
This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.
Eligibility
Inclusion Criteria2
- At least 6 months of age
- Admitted to an inpatient unit at a participating health system
Exclusion Criteria4
- \- Admission to critical care sites or hematology-oncology services
- At least 6 months of age
- Admitted to an inpatient unit at a participating health system
- \- Admission to critical care sites or hematology-oncology services
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Usual care is defined as the existing inpatient influenza vaccination practices that currently exist at a given site.
Intervention A: The basic intervention is the inpatient influenza vaccination program Intervention B: The intensified intervention is the multifaceted influenza vaccination strategy (Intervention A) plus a learning collaborative
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05832307